Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Show full item record



Permalink

http://hdl.handle.net/10138/315579

Citation

MASK Grp , Menditto , E , Costa , E , Midao , L , Haahtela , T , Toppila-Salmi , S , Kuitunen , M & Valovirta , E 2019 , ' Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study ' , Clinical and Experimental Allergy , vol. 49 , no. 4 , pp. 442-460 . https://doi.org/10.1111/cea.13333

Title: Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
Author: MASK Grp; Menditto, Enrica; Costa, Elisio; Midao, Luis; Haahtela, Tari; Toppila-Salmi, S.; Kuitunen, M.; Valovirta, E.
Other contributor: University of Helsinki, Department of Dermatology, Allergology and Venereology
University of Helsinki, Department of Dermatology, Allergology and Venereology
University of Helsinki, Children's Hospital





Date: 2019-04
Language: eng
Number of pages: 19
Belongs to series: Clinical and Experimental Allergy
ISSN: 0954-7894
DOI: https://doi.org/10.1111/cea.13333
URI: http://hdl.handle.net/10138/315579
Abstract: Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported >= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR >= 70% and PDC = 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.
Subject: adherence
mHealth
mobile technology
observational study
rhinitis
treatment
CONTROLLER MEDICATION
K-ANONYMITY
ASTHMA
PERSISTENCE
VALIDATION
THERAPY
DISEASE
TRIAL
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Menditto_et_al_ ... 6_Experimental_Allergy.pdf 966.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record